Navigation Links
Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr. Robert Garnick as Head of Regulatory Affairs
Date:10/19/2009

is a welcome addition to the team at Peregrine, joining at an opportune time as we have just recently completed enrollment in all three of our ongoing bavituximab Phase II cancer trials, as well as a bavituximab Phase I cancer trial. He brings a tremendous amount of enthusiasm and experience across many different areas that will be very valuable as we continue to advance our clinical and preclinical programs."

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and serious virus infections. The company is pursuing three separate clinical programs in cancer and HCV infection with its lead product candidates bavituximab and Cotara®. Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (www.avidbio.com), which provides development and bio-manufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at www.peregrineinc.com.

Safe Harbor Statement: Statements in this press release which are not purely historical, including statements regarding Peregrine Pharmaceuticals' intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. It is important to note that the company's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, uncertainties associated with completing preclinical and clinical trials for our technologies; the early stage of product development; the significant costs to develop our products as all of our products are currently in
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Peregrine Pharmaceuticals Forms Anti-Viral Research Group to Oversee Its Anti-PS Infectious Disease Collaborations
2. Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrines Cotara(R) for Treatment of Brain Cancer
3. Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials
4. Peregrine Pharmaceuticals Completes Patient Enrollment in its Phase II Trial of Bavituximab Plus Docetaxel in Breast Cancer Patients
5. Affitech-Discovered Anti-PS Antibodies in Development by Peregrine Pharmaceuticals Show Excellent Functionality in Preclinical Studies
6. Data Presented at AACR Annual Meeting Show Anti-Tumor Activity of Peregrines Fully Human Anti-PS Antibody in Prostate Cancer Model
7. Studies Presented at AACR Annual Meeting Highlight Multiple Immunomodulatory Mechanisms of Peregrines PS-Targeting Antibodies
8. Peregrine Pharmaceuticals Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial
9. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial
10. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
11. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... N.C. , May 22, 2013 STEPh, ... to announce the launch of their web site ( ... [STEPh Reports].  About STEPh Reports ... in development.  Each STEPh Report assesses ... trials data, projected launch year, company, and specific key ...
(Date:5/22/2013)... INDEPENDENCE, Ohio , May 22, 2013   ... of health screening services announced today the creation of ... Health (MCM) . MCM is a ... services to MCM,s growing list of clients. These important ... in costly chronic conditions earlier. Effective prevention reduces cost ...
(Date:5/22/2013)...  Grifols, ein globales Unternehmen der Gesundheitsbranche ... , Spanien, präsentierte die Ergebnisse einer Studie, ... PROLASTIN©-C (Alpha1-Proteinasehemmer [human]) den Spiegel des Alpha1-Proteins ... Niveau anhebt, das innerhalb des für gesunde ... eine lebensbedrohliche, genetische Erkrankung, bei der der ...
Breaking Medicine Technology:Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2Life Line Screening and MCM Solutions for Better Health Announce New Partnership 2Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 2Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 3Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 4
... Ind., Feb. 14, 2012  Heraeus Kulzer, LLC, the worldwide ... Metal Refining Division donated almost $20,000 to the ... A non-profit organization founded in 2008 with ... Laboratories (NADL), FDLT,s purpose is to advance the profession ...
... 14, 2012 SCOLR Pharma, Inc. (OTCQB: SCLR) announced ... had previously obtained the exclusive worldwide rights to use ... ondansetron, will conduct a bioequivalence trial in Canada.  Both ... Canada have reviewed the protocol for the study and ...
Cached Medicine Technology:Heraeus' Precious Metal Refining Division Donates Nearly $20,000 to Foundation for Dental Laboratory Technology 2Heraeus' Precious Metal Refining Division Donates Nearly $20,000 to Foundation for Dental Laboratory Technology 3Heraeus' Precious Metal Refining Division Donates Nearly $20,000 to Foundation for Dental Laboratory Technology 4SCOLR Pharma's Partner to Commence Bioequivalence Study of Ondansetron 2SCOLR Pharma's Partner to Commence Bioequivalence Study of Ondansetron 3
(Date:5/23/2013)... 2013 Shirataki noodles are ... part of a diet strategy. These noodles are originally ... konjac plant. When losing weight, diet and exercise are ... website helping dieters not only research shirataki noodles but ... where to buy them. Shirataki noodles are ...
(Date:5/23/2013)... GBI Research’s analysis indicates that the global ... small number of players accounting for a major proportion of ... growth rate between 2006 and 2012, possibly due to the ... markets, especially in the US. , GBI Research estimates ... billion in 2012, having grown in size at a CAGR ...
(Date:5/22/2013)... Prairie, WI (PRWEB) May 23, 2013 ... , introduced a new feature to its website ... from the agency’s client portfolio through an immersive, 360-degree, ... clients and prospective customers the ability to virtually experience ... a developer of medical technologies and services. Users have ...
(Date:5/22/2013)... CA (PRWEB) May 22, 2013 Dr. Andrew ... to painful scalpel surgery with the Laser Assisted New Attachment ... is raising awareness about the connections between gum disease and ... concerns in the United States today, and is linked to ... of bacteria found in the infected gum pockets. , ...
(Date:5/22/2013)... 2013 Hosted by the California Dental ... clinic provided more than $1.6 million in charitable dental ... San Jose. , The California Dental Association Foundation ... provide free dental services and oral health education to ... third clinic held by CDA and CDAF in the ...
Breaking Medicine News(10 mins):Health News:DietNoodleShop.com is Re-launching; Adding More Diet Recipes Along with Information on Shirataki Noodles 2Health News:MarketResearch.com Report – Increased Cost of Albumin was Main Factor for Double-Digit Growth of Global Critical Care Market Between 2006 and 2012 2Health News:Catalyst Exhibits Debuts 360 Degree Virtual Tour of St. Jude Medical Trade Show Booth 2Health News:For Stroke Awareness Month, Dr. Andrew Satlin is Raising Awareness of the Connections Between Gum Disease and Stroke and Offers Encino, CA Laser Gum Surgery for Treatment 2Health News:Two-day San Jose Dental Clinic Provides More Than $1.6 Million in Care 2
... N.Y. -- Vietnam War-era veterans exposed to Agent Orange ... disorder, than veterans with no exposure, a new study ... Ajay Varanasi, MD, an endocrinology fellow in ... the study, garnered first prize in the oral presentation ...
... one of the world,s deadliest diseases may lie within ... of Central Florida scientist Debopam Chakrabarti is analyzing more ... sea near Florida,s coast. Some of them could hold ... mosquito-borne illness that kills more than 1 million people ...
... University of Leicester is set to play a vital role ... many families find to be unpleasant. The research team ... has won a substantive award by the National Institute for ... cardiac angiography in relation to near virtual autopsies. ...
... A ... on losing weight. It looks at how ephedrine products affect the body,s energy levels, control ... ... article that examines ephedrine HCL and its effects on weight loss. This article, entitled " ...
... To ... or 202.684.3728. , ... (Vocus) June 28, 2010 -- With the deadline fast approaching for new federal rules implementing ... has sent a letter, also signed by many of his colleagues, to the Departments of ...
... HealthDay Reporter , SUNDAY, June 27 (HealthDay News) -- ... gain greater blood sugar control overnight, even when they have ... The promise of this emerging technology is to free diabetics ... by letting a computer program do the job -- constantly ...
Cached Medicine News:Health News:Agent Orange exposure linked to Graves' disease in Vietnam veterans, UB study finds 2Health News:Underwater sponges and worms may hold key to cure for malaria 2Health News:New Article Re-Examines Ephedrine HCL Products For Weight Loss 2Health News:National Council Applauds Rep. Tonko for Seeking Strict Enforcement of Mental Health Parity Law – July 1, 2010 Deadline Approaching 2Health News:Artificial Pancreas Continues to Show Promise 2Health News:Artificial Pancreas Continues to Show Promise 3Health News:Artificial Pancreas Continues to Show Promise 4
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
... and value!, Comfortable feel and ... contoured handle , Finer control while ... action , Completely autoclavable for easy ... for recalibration , Easy-to-read precision micrometer ...
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
... the specialty areas of cardiac ... care work, it is essential ... practice. Alokas motorized TEE transducer ... Tissue Harmonic Echo technology allows ...
Medicine Products: